Literature DB >> 24958075

Vaccine-preventable diseases in Europe: where do we stand?

Sabine Wicker1, Helena C Maltezou.   

Abstract

During the second half of the 20th century, vaccinations led to the control or even eradication of several vaccine-preventable diseases (VPDs) in Europe. However, outbreaks of VPDs continue to occur even in countries with well-established vaccination programs. Reasons include the existence of under-vaccinated populations, the increasing anti-vaccination movement and the increasing movement of populations across borders. Ensuring adequate levels of herd immunity is the only reliable method for preventing epidemics and a re-emergence of VPDs. In order to achieve this, more flexible vaccine delivery platforms are needed targeting the less-privileged people, especially in the context of the current economic crisis. Healthcare personnel and healthcare systems should be prepared to address these challenges in the following years.

Entities:  

Keywords:  Europe; control; eradication; immunization; outbreaks; re-emergence; vaccination; vaccine-preventable diseases

Mesh:

Substances:

Year:  2014        PMID: 24958075     DOI: 10.1586/14760584.2014.933077

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  13 in total

Review 1.  Challenges for nationwide vaccine delivery in African countries.

Authors:  Mario Songane
Journal:  Int J Health Econ Manag       Date:  2017-10-19

2.  The Economic Value of Vaccination: Why Prevention is Wealth.

Authors: 
Journal:  J Mark Access Health Policy       Date:  2015-08-12

Review 3.  Pneumococcal vaccination in autoimmune rheumatic diseases.

Authors:  Éva Rákóczi; Zoltan Szekanecz
Journal:  RMD Open       Date:  2017-09-14

4.  Mandatory vaccination: suited to enhance vaccination coverage in Europe?

Authors:  Heidemarie Holzmann; Ursula Wiedermann
Journal:  Euro Surveill       Date:  2019-06

5.  National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning.

Authors:  Walter Ricciardi; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2015-09-14

6.  From population to public institutions: what needs to be changed to benefit from the full value of vaccination.

Authors:  Thomas Szucs; Sibilia Quilici; Marina Panfilo
Journal:  J Mark Access Health Policy       Date:  2015-08-12

7.  Vaccination: the cornerstone of an efficient healthcare system.

Authors:  Vanessa Rémy; York Zöllner; Ulrike Heckmann
Journal:  J Mark Access Health Policy       Date:  2015-08-12

Review 8.  Measles among migrants in the European Union and the European Economic Area.

Authors:  Gemma A Williams; Sabrina Bacci; Rebecca Shadwick; Taavi Tillmann; Bernd Rechel; Teymur Noori; Jonathan E Suk; Anna Odone; Jonathan D Ingleby; Philipa Mladovsky; Martin Mckee
Journal:  Scand J Public Health       Date:  2015-11-12       Impact factor: 3.021

9.  A process evaluation of how the routine vaccination programme is implemented at GP practices in England.

Authors:  Tim Crocker-Buque; Michael Edelstein; Sandra Mounier-Jack
Journal:  Implement Sci       Date:  2018-10-22       Impact factor: 7.327

10.  Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia.

Authors:  Yvonne S K Khoo; A Ab Ghani; A A Navamukundan; R Jahis; A Gamil
Journal:  Hum Vaccin Immunother       Date:  2019-10-25       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.